No evidence for JAK2V617F mutation in monoclonal B Cells in 2 patients with polycythaemia vera and concurrent monoclonal B cell disorder

Acta Haematologica

Volumn 128, Issue 3, 2012, Pages 183-186

  Stijnis, C ^a,b,c   Kroes, W G M ^a   Balkassmi, S ^a   Marijt, E W A ^a   Van Rossum, A P ^b   Bakker, E ^a   Vlasveld, L T ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

JAK2V617F mutation; Monoclonal B cell disorder; Polycythaemia vera

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CASE REPORT; DENSITY GRADIENT CENTRIFUGATION; GENE; GENE MUTATION; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; JAK2 V617F GENE; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; MONOCYTE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLENOMEGALY; T LYMPHOCYTE;

AGED; B-LYMPHOCYTES; HUMANS; JANUS KINASE 2; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA;

EID: 84864815381     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000338831     Document Type: Article

References (17)

1. Campbell PJ, Green AR: The myeloproliferative disorders. N Engl J Med 2006; 355: 2452-2466.
2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054-1056.
3. Poulain S, Merchez M, Daudignon A, Simon M, Duthilleul P, Morel P: Jak V617F mutation is absent in chronic lymphocytic leukaemia. Leuk Lymphoma 2006; 47: 2657-2658.
4. Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, Jones C, Zehnder JL, Lilleberg SL, Weissman IL: The JAK2 V617F mutation occurs in haematopoietic stem cells in polycythaemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci USA 2006; 103: 6224-6229.
5. Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K: Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011; 20: 246-259.
6. Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N: The JAK2 V617F mutation involves B-and T-lymphocyte lineages in a subgroup of patients with Philadelphiachromosome negative chronic myeloproliferative disorders. Br J Haematol 2007; 136: 745-751.
7. Delhommeau F, Dupont S, Tonetti C, Massé A, Godin I, Le Couedic JP, Debili N, Saulnier P, Casadevall N, Vainchenker W, Giraudier S: Evidence that the JAK2 G1849T (V617) mutation occurs in a lymphomyeloid progenitor in polycythaemia vera and idiopathic myelofibrosis. Blood 2007; 109: 71-77.
8. Bogani C, Guglielmelli P, Antonioli E, Pancrazzi A, Bosi A, Vannuchi AM: B-, T-, and NK-cell lineage involvement in JAK2 V617F positive patients with idiopathic myelofibrosis. Haematologica 2007; 92: 258-259.
9. Rashind WH, Jacobson R, Murphy S, Adamson JW, Fialkow PJ: Evidence for the involvement of B lymphoid cells in polycythaemia vera and essential thrombocythaemia. J Clin Invest 1985; 75: 1388-1390.
10. Ballard HS, Kouri Y: The association of erythrocytosis and chronic lymphocytic leukaemia. Cancer 1992; 70: 2431-2435.
11. Nieto LH, Sánchez JMR: Diagnóstic simultáneo de leukemia linfocítica crónica y policitemia vera en un paciente. An Med Interna 2002; 19: 61.
12. Hussein K, Brakensiek K, Ballmaier M, Bormann M, Göhring G, Buhr T, Bock O, Kreipe H: B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 2006; 77: 539-541.
13. Henry L, Carillo S, Jourdan E, Arnaud A, Brun S, Lavabre-Bertrand T: Association of essential thrombocythaemia and chronic lymphocytic leukaemia: absence of the JAK2 V617F mutation in the lymphoid compartment. Am J Hematol 2007; 82: 500-501.
14. Musolino C, Allegra A, Penna G, Centorrino R, Cuzzola M, D'Angelo A, Iacopino P, Alonci A: Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythaemia and B-chronic lymphocytic leukaemia and two relatives with lymphoproliferative disorders. Acta Haematol 2009; 122: 46-49.
15. Kodali S, Chen C, Rathnasabapathy C, Wang JC: JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res 2009; 33:e236-e239.
16. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R: The coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasms: a retrospective multicentric GINEMA experience. Am J Hematol 2011; 86: 1007-1012.
17. Tan AY, Westerman DA, Dobrovic A: A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation. Am J Clin Pathol 2007; 127: 977-981.